Skip to main content
. 2017 Nov 28;5:Doc08. doi: 10.3205/id000034

Table 2. Clinical antiviral activity of the most important approved protease inhibitors (mean or median maximum HCV viral load decline after 3–14 days’ monotherapy [log10 IU/ml].

Table 2

adapted from Sarrazin 2016 [19]